|
1
|
Goodenberger ML and Jenkins RB: Genetics
of adult glioma. Cancer Genet. 205:613–621. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stewart LA: Chemotherapy in adult
high-grade glioma: A systematic review and meta-analysis of
individual patient data from 12 randomised trials. Lancet.
359:1011–1018. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhu VF, Yang J, Lebrun DG and Li M:
Understanding the role of cytokines in Glioblastoma Multiforme
pathogenesis. Cancer Lett. 316:139–150. 2012. View Article : Google Scholar
|
|
4
|
Sathornsumetee S, Reardon DA, Desjardins
A, Quinn JA, Vredenburgh JJ and Rich JN: Molecularly targeted
therapy for malignant glioma. Cancer. 110:13–24. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pulkkanen KJ and Yla-Herttuala S: Gene
therapy for malignant glioma: Current clinical status. Mol Ther.
12:585–598. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Marumoto T and Saya H: Molecular biology
of glioma. Adv Exp Med Biol. 746:2–11. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen C and Wang G: Mechanisms of
hepatocellular carcinoma and challenges and opportunities for
molecular targeted therapy. World J Hepatol. 7:1964–1970. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tessitore A, Cicciarelli G, Del Vecchio F,
Gaggiano A, Verzella D, Fischietti M, Vecchiotti D, Capece D,
Zazzeroni F and Alesse E: MicroRNAs in the DNA Damage/Repair
Network and Cancer. Int J Genomics. 2014:8202482014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Brower JV, Clark PA, Lyon W and Kuo JS:
MicroRNAs in cancer: Glioblastoma and glioblastoma cancer stem
cells. Neurochem Int. 77:68–77. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Auffinger B, Thaci B, Ahmed A, Ulasov I
and Lesniak MS: MicroRNA targeting as a therapeutic strategy
against glioma. Curr Mol Med. 13:535–542. 2013. View Article : Google Scholar
|
|
13
|
Li X, Ling N, Bai Y, Dong W, Hui GZ, Liu
D, Zhao J and Hu J: MiR-16-1 plays a role in reducing migration and
invasion of glioma cells. Anat Rec (Hoboken). 296:427–432. 2013.
View Article : Google Scholar
|
|
14
|
Malzkorn B, Wolter M, Liesenberg F,
Grzendowski M, Stühler K, Meyer HE and Reifenberger G:
Identification and functional characterization of microRNAs
involved in the malignant progression of gliomas. Brain Pathol.
20:539–550. 2010. View Article : Google Scholar
|
|
15
|
Chen F, Chen L, He H, Huang W, Zhang R, Li
P, Meng Y and Jiang X: Up-regulation of microRNA-16 in glioblastoma
inhibits the function of endothelial cells and tumor angiogenesis
by targeting Bmi-1. Anticancer Agents Med Chem. 16:609–620. 2016.
View Article : Google Scholar
|
|
16
|
Wang Q, Li X, Zhu Y and Yang P:
MicroRNA-16 suppresses epithelial-mesenchymal transition related
gene expression in human glioma. Mol Med Rep. 10:3310–3314.
2014.PubMed/NCBI
|
|
17
|
Yang TQ, Lu XJ, Wu TF, Ding DD, Zhao ZH,
Chen GL, Xie XS, Li B, Wei YX, Guo LC, et al: MicroRNA-16 inhibits
glioma cell growth and invasion through suppression of Bcl-2 and
the nuclear factor-κB1/MMP9 signaling pathway. Cancer Sci.
105:265–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ambros V: microRNAs: Tiny regulators with
great potential. Cell. 107:823–826. 2001. View Article : Google Scholar
|
|
19
|
Chen X, Vega VB and Ng HH: Transcriptional
regulatory networks in embryonic stem cells. Cold Spring Harb Symp
Quant Biol. 73:203–209. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang X, Yuan X, Zhu W, Qian H and Xu W:
SALL4: An emerging cancer biomarker and target. Cancer Lett.
357:55–62. 2015. View Article : Google Scholar
|
|
21
|
Oishi N, Yamashita T and Kaneko S:
Molecular biology of liver cancer stem cells. Liver Cancer.
3:71–84. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang L, Yan Y, Jiang Y, Cui Y, Zou Y,
Qian J, Luo C, Lu Y and Wu X: The expression of SALL4 in patients
with gliomas: High level of SALL4 expression is correlated with
poor outcome. J Neurooncol. 121:261–268. 2015. View Article : Google Scholar
|
|
23
|
He J, Zhang W, Zhou Q, Zhao T, Song Y,
Chai L and Li Y: Low-expression of microRNA-107 inhibits cell
apoptosis in glioma by upregulation of SALL4. Int J Biochem Cell
Biol. 45:1962–1973. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cunliffe CH, Fischer I, Parag Y and Fowkes
ME: State-of-the-art pathology: new WHO classification,
implications, and new developments. Neuroimaging Clin N Am.
20:259–271. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Suzuki HI, Yamagata K, Sugimoto K, Iwamoto
T, Kato S and Miyazono K: Modulation of microRNA processing by p53.
Nature. 460:529–533. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Amaral FC, Torres N, Saggioro F, Neder L,
Machado HR, Silva WA Jr, Moreira AC and Castro M: MicroRNAs
differentially expressed in ACTH-secreting pituitary tumors. J Clin
Endocrinol Metab. 94:320–323. 2009. View Article : Google Scholar
|
|
27
|
Cimmino A, Calin GA, Fabbri M, Iorio MV,
Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, et
al: miR-15 and miR-16 induce apoptosis by targeting Bcl-2. Proc
Natl Acad Sci USA. 102:13944–13949. 2005. View Article : Google Scholar
|
|
28
|
Oikawa T, Kamiya A, Zeniya M, Chikada H,
Hyuck AD, Yamazaki Y, Wauthier E, Tajiri H, Miller LD, Wang XW, et
al: Sal-like protein 4 (SALL4), a stem cell biomarker in liver
cancers. Hepatology. 57:1469–1483. 2013. View Article : Google Scholar
|
|
29
|
Li A, Jiao Y, Yong KJ, Wang F, Gao C, Yan
B, Srivastava S, Lim GS, Tang P, Yang H, et al: SALL4 is a new
target in endometrial cancer. Oncogene. 34:63–72. 2015. View Article : Google Scholar
|
|
30
|
Kobayashi D, Kuribayashi K, Tanaka M and
Watanabe N: Overexpression of SALL4 in lung cancer and its
importance in cell proliferation. Oncol Rep. 26:965–970.
2011.PubMed/NCBI
|
|
31
|
Ardalan Khales S, Abbaszadegan MR,
Abdollahi A, Raeisossadati R, Tousi MF and Forghanifard MM: SALL4
as a new biomarker for early colorectal cancers. J Cancer Res Clin
Oncol. 141:229–235. 2015. View Article : Google Scholar
|
|
32
|
Forghanifard MM, Ardalan Khales S,
Javdani-Mallak A, Rad A, Farshchian M and Abbaszadegan MR: Stemness
state regulators SALL4 and SOX2 are involved in progression and
invasiveness of esophageal squamous cell carcinoma. Med Oncol.
31:9222014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Itou J, Matsumoto Y, Yoshikawa K and Toi
M: Sal-like 4 (SALL4) suppresses CDH1 expression and maintains cell
dispersion in basal-like breast cancer. FEBS Lett. 587:3115–3121.
2013. View Article : Google Scholar : PubMed/NCBI
|
